Related insights: Pharmaceutical and Medical Device Litigation

Making Sense of FDA’s Recent Guidances on Personal Protective Equipment (PPE)

Apr 08 2020

To address the COVID-19 public health crisis, FDA issued two immediately in effect guidance documents: FDA Guidance for Industry (April 2020) Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised), and FDA Guidance for Industry (March 2020) Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency.

COVID-19 Liability Immunity - What You Need to Know Now

Apr 06 2020

The Secretary of the Department of Health and Human Services issued a declaration providing liability immunity to certain individuals and entities against covered claims of loss relating to the manufacture, distribution, administration, or use of medical countermeasures (“Covered Countermeasures”), except for claims involving “willful misconduct.” The COVID-19 Declaration was issued on March 10, 2020 under the authority of the Public Readiness and Emergency Preparedness Act of 2005 (“PREP Act”), codified at 42 U.S.C. §247d-6d, and is retroactively effective beginning February 4, 2020.

Rising Star Litigation Partner Joins Womble Bond Dickinson

Sep 06 2019

Womble Bond Dickinson has strengthened its Product Liability Litigation practice in the firm’s Atlanta office with the addition of Sara Tucker, a veteran mass torts litigator with deep experience in medical device and pharmaceutical litigation.

Womble Bond Dickinson’s Dan Orr to Co-Lead Biosimilars Regulation Webinar on Feb. 14

Feb 06 2019

Womble Bond Dickinson attorney Dan Orr will be a co-presenter at the “Biosimilars Regulation: Latest Regulatory, Compliance & Approval Developments” webinar.

J. Marshall Allen Discusses Private Equity Acquisition of Physician Practice: An Alternative to Acquisition by Hospital System

Oct 09 2017

Womble Carlyle Healthcare attorney, J. Marshall Allen and Don Johnson II, MD presented “Private Equity Acquisition of Physician Practice: An Alternative to Acquisition by Hospital System” to The South Carolina Spine Society at the Mills House Hotel on Saturday, September 30, 2017.

Veteran Life Sciences IP/Patent Attorneys Danielle Herritt, Deborah Vernon and Cristin Cowles Join Womble Carlyle’s Boston Office

Oct 02 2017

A trio of experienced patent partners and their team are making the move to Womble Carlyle’s new Boston office.

11th Circuit Court of Appeals Mandates Proactive Gathering and Review of SSA Information in Fiduciary’s LTD Benefit Review

Feb 11 2014

Not long ago, the Unites States Supreme Court in MetLife v. Glenn, 128 S. Ct. 2343 (2008) gave a stern warning to plan fiduciaries who required a claimant to apply for disability benefits with the Social Security Administration (SSA) and benefited from an SSA approval because of the offset, and then failed to adequately distinguish its benefit denial from the SSA’s approval: This, the Court declared, not only “suggested procedural unreasonableness,” but also could be important in weighing the factors related to the inherent conflict of interest when the fiduciary was also the payer of benefits. Id. at 2352.

Related insights: Pharmaceutical and Medical Device Litigation

Making Sense of FDA’s Recent Guidances on Personal Protective Equipment (PPE)

COVID-19 Liability Immunity - What You Need to Know Now

Rising Star Litigation Partner Joins Womble Bond Dickinson

Womble Bond Dickinson’s Dan Orr to Co-Lead Biosimilars Regulation Webinar on Feb. 14

J. Marshall Allen Discusses Private Equity Acquisition of Physician Practice: An Alternative to Acquisition by Hospital System

Veteran Life Sciences IP/Patent Attorneys Danielle Herritt, Deborah Vernon and Cristin Cowles Join Womble Carlyle’s Boston Office

11th Circuit Court of Appeals Mandates Proactive Gathering and Review of SSA Information in Fiduciary’s LTD Benefit Review

Insights

Contact